Growth
Dan Zanger: Leader
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Zanger's real strategy (not the widely circulated 'Liquid High Beta' variant). He buys institutional market leaders: explosive earnings growth (≥ 50%), top relative strength, high-priced liquid stocks near their highs, market cap up to $10 billion — and only enters on a volume breakout (≥ 300% of average) out of a base. This screener delivers the leader watchlist; the breakout itself is discretionary. 70% technical, 30% fundamental, inspired by O'Neil's CAN SLIM.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(20)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Beta
- Measures how much a stock swings relative to the overall market: a beta of 2 means it moves on average twice as much as the market - in both directions.
- Breakout
- The price clears a level where it previously failed multiple times (top of a base, an old high) - ideally on clearly elevated volume. For many momentum strategies, the breakout is the actual buy signal.
- CANSLIM
- William O'Neil's strategy framework, whose seven letters each mark a criterion - among them current earnings growth, new products/highs, institutional sponsorship, and market direction. Core idea: buy the market leaders, not the laggards.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Institutions (Funds & Large Holders)
- Funds, pension plans, and asset managers - they move the big money and must disclose their US holdings quarterly. When the number of funds adding to a position rises, that is called institutional accumulation: the fuel behind major trends.
- Liquidity
- How easily a stock can be bought and sold without moving the price - measured by (dollar) volume. Illiquid stocks have wide spreads and jerky prices; that is why almost every scanner applies a minimum liquidity filter.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FORM FormFactor Inc | 07/29 | +126 % | 87 9/25 | Stage 2 | A 75 | 8 of 9 | 9.1 $ | Semiconductor Equipment & Materials | Uses AI | — | — | Technology | 106.20 $ | +156.0 % | +147.9 % | +273.8 % | −6.5 % | +30.5 % | 97 | 91 | 9.4 % | 8.6 % | 1.22 | 107.3 | 39.5 | 10.8 | 6.9 | 248.1 | 1.39 | 44.7 | 17.7 % | 46.2 % | 12.8 % | 6.8 % | 7.3 % | 0.04 | 84.3 % | +2.8 % | — | 0.0 % | 0.0 % | 12.3 | 98.8 % | 5.1 % | 3.7 (10) |
| ATEX Anterix Inc | 08/11 | +51 % | 89 9/24 | Stage 2 | A 78 | 7 of 9 | 1.8 $ | Telecom Services | Neutral | — | Communication Services | 93.00 $ | +266.4 % | +339.9 % | +318.8 % | −8.1 % | +15.8 % | 97 | 85 | 8.3 % | 8.2 % | 0.83 | 21.3 | 0.0 | 266.2 | 7.7 | 319.5 | — | -12.4 | — | 100.0 % | 1,394.2 % | 43.3 % | -6.5 % | 0.02 | — | +7.8 % | — | 0.0 % | 0.0 % | 3.5 | 91.8 % | 16.9 % | 4.7 (3) | |
| AGX Argan Inc | — | +629 % | 85 10/29 | Stage 2 | A 78 | 5 of 9 | 8.6 $ | Engineering & Construction | Uses AI | — | — | Industrials | 570.40 $ | +135.6 % | +141.6 % | +134.0 % | −4.8 % | +19.2 % | 96 | 86 | 7.0 % | 7.0 % | 0.56 | 50.9 | 16.6 | 8.2 | 16.9 | 17.6 | — | 43.3 | 15.6 % | 20.7 % | 15.5 % | 38.5 % | 9.4 % | — | 36.8 % | +8.1 % | — | 0.4 % | 17.6 % | 8.1 | 108.9 % | 6.7 % | 4.0 (2) |
| GTX Garrett Motion Inc | 07/23 | +124 % | 64 8/31 | Stage 2 | B 60 | 8 of 9 | 5.8 $ | Auto Parts | Uses AI | — | Consumer Cyclical | 31.20 $ | +94.9 % | +102.6 % | +142.7 % | −0.6 % | +17.0 % | 96 | 80 | 3.6 % | 4.0 % | 0.79 | 18.3 | 17.1 | 1.6 | 0.0 | 15.4 | — | 10.7 | 14.1 % | 20.8 % | 9.5 % | 0.0 % | 14.1 % | -1.88 | -32.9 % | +3.1 % | — | 1.0 % | 17.3 % | 2.6 | 96.1 % | 2.9 % | 4.0 (1) | |
| SNEX Stonex Group Inc | 08/04 | +151 % | 68 6/22 | Stage 2 | B 57 | 6 of 9 | 9.2 $ | Capital Markets | Neutral | — | Financial Services | 76.60 $ | +117.5 % | +77.2 % | +77.2 % | −3.3 % | +46.2 % | 95 | 87 | 6.0 % | 4.9 % | 0.66 | 20.3 | 9.8 | 0.1 | 3.3 | 1.2 | — | 11.5 | 0.5 % | 1.6 % | 0.3 % | 20.2 % | 1.1 % | 7.16 | 5.0 % | +32.5 % | — | 0.0 % | 0.0 % | 5.5 | 85.9 % | 7.1 % | 5.0 (2) | |
| MYRG MYR Group Inc | 07/29 | +84 % | 76 9/29 | Stage 2 | B 68 | 9 of 9 | 5.4 $ | Engineering & Construction | Neutral | — | Industrials | 333.20 $ | +114.2 % | +120.8 % | +72.2 % | −0.9 % | +30.0 % | 95 | 86 | 5.2 % | 5.4 % | 1.31 | 36.1 | 28.0 | 1.3 | 7.2 | 27.7 | 3.41 | 17.3 | 6.4 % | 12.5 % | 4.1 % | 22.7 % | 8.5 % | 0.11 | 42.0 % | +8.8 % | — | 0.0 % | 0.0 % | 6.9 | 104.4 % | 6.1 % | 4.6 (5) | |
| ATRO Astronics Corporation | 08/05 | +154 % | 76 9/29 | Stage 2 | B 56 | 6 of 9 | 3.4 $ | Aerospace & Defense | Neutral | — | Industrials | 69.50 $ | +91.0 % | +94.2 % | +141.1 % | −12.8 % | +14.4 % | 95 | 89 | 6.0 % | 5.8 % | 1.13 | — | 27.2 | 3.8 | — | 136.9 | 1.46 | 33.6 | 11.8 % | 31.4 % | 5.1 % | 21.2 % | 9.0 % | — | 21.6 % | +8.4 % | — | 0.0 % | 0.0 % | 7.9 | 101.1 % | 8.0 % | 3.3 (3) | |
| CEVA CEVA Inc | 08/10 | +32 % | 73 7/25 | Stage 2 | C 52 | 1 of 9 | 0.9 $ | Semiconductors | – | — | — | Technology | 32.70 $ | +111.3 % | +97.2 % | +52.8 % | −14.9 % | +52.9 % | 95 | 85 | 8.4 % | 8.2 % | 1.97 | — | 64.1 | 8.1 | 2.7 | — | 3.20 | 126.8 | — | 87.2 % | -10.5 % | -3.9 % | -2.2 % | 0.05 | — | +2.5 % | — | 0.0 % | 0.0 % | 14.5 | 92.3 % | 7.4 % | 4.8 (8) |
| OSCR Oscar Health Inc | 08/05 | +84 % | 79 7/22 | Stage 2 | B 64 | 7 of 9 | 9.0 $ | Healthcare Plans | Uses AI | — | — | Healthcare | 31.20 $ | +108.3 % | +97.3 % | +122.2 % | −5.6 % | -19.2 % | 94 | 87 | 5.6 % | 6.6 % | 2.34 | — | 588.2 | 0.7 | 5.7 | 3.2 | — | 0.0 | 15.2 % | 17.4 % | -0.3 % | -2.6 % | 0.1 % | 0.26 | 17.9 % | +27.5 % | — | 0.0 % | 0.0 % | 3.0 | 67.6 % | 8.0 % | 3.3 (7) |
| BHE Benchmark Electronics Inc | 07/29 | +95 % | 87 9/25 | Stage 2 | B 61 | 8 of 9 | 2.9 $ | Electronic Components | Neutral | — | Technology | 79.80 $ | +113.2 % | +113.5 % | +110.0 % | −1.3 % | +7.8 % | 94 | 92 | 5.0 % | 4.8 % | 1.26 | 80.6 | 14.1 | 1.0 | 2.6 | 23.1 | 1.33 | 19.2 | 3.8 % | 10.3 % | 1.9 % | 3.1 % | 3.1 % | 0.28 | 52.3 % | +0.1 % | — | 0.9 % | 27.1 % | 8.1 | 107.4 % | 5.0 % | 4.0 (3) | |
| SEI Solaris Energy Infrastructure, Inc | 07/22 | +327 % | 79 3/10 | Stage 2 | B 73 | 5 of 9 | 5.1 $ | Oil & Gas Equipment & Services | Sells AI | — | Energy | 51.40 $ | +70.3 % | +76.6 % | +59.0 % | −7.8 % | +83.5 % | 92 | 87 | 7.0 % | 7.1 % | 1.18 | — | 384.6 | 7.3 | — | — | 0.94 | 20.2 | 25.8 % | 46.9 % | 6.7 % | 8.7 % | 5.0 % | — | 26.1 % | +98.7 % | — | 0.9 % | 66.7 % | 4.1 | 113.1 % | 26.1 % | 4.9 (8) | |
| MRX Marex Group plc Ordinary Shares | 08/12 | — | 79 7/22 | Stage 2 | B 61 | 4 of 9 | 4.6 $ | Capital Markets | – | — | — | Financial Services | 64.90 $ | +74.6 % | +49.3 % | +70.9 % | −4.8 % | +11.5 % | 92 | 79 | 4.9 % | 4.7 % | -0.09 | 14.7 | 8.8 | 0.8 | 3.5 | — | — | 6.1 | 13.1 % | 68.9 % | 10.6 % | 29.1 % | 1.1 % | — | 3.7 % | +25.4 % | — | 1.0 % | 17.1 % | 4.2 | 75.2 % | 5.1 % | 4.3 (8) |
| HLIO Helios Technologies Inc | 08/03 | +15 % | 37 5/29 | Stage 2 | B 67 | 9 of 9 | 2.6 $ | Specialty Industrial Machinery | – | — | — | Industrials | 77.90 $ | +67.8 % | +61.8 % | +113.7 % | −2.3 % | +13.6 % | 91 | 89 | 4.0 % | 3.8 % | 1.26 | — | 11.7 | 3.0 | — | 23.9 | 1.03 | 17.8 | 13.1 % | 32.9 % | 7.0 % | 6.7 % | 4.4 % | — | 61.9 % | +4.1 % | — | 0.6 % | 18.0 % | 7.8 | 101.8 % | 2.9 % | 4.4 (5) |
| TGTX TG Therapeutics Inc | 08/03 | +43 % | 53 5/22 | Stage 2 | B 68 | 5 of 9 | 8.0 $ | Biotechnology | Neutral | — | Healthcare | 52.00 $ | +80.9 % | +79.3 % | +46.6 % | −6.5 % | +31.6 % | 90 | 92 | 5.0 % | 4.8 % | 1.60 | 18.9 | 55.2 | 11.5 | 14.2 | — | 1.61 | 54.6 | 17.0 % | 83.1 % | 66.0 % | 112.6 % | 8.6 % | 1.29 | 38.1 % | +87.3 % | — | 0.0 % | 0.0 % | 6.2 | 70.2 % | 29.0 % | 4.3 (9) | |
| INDV Indivior Pharmaceuticals, Inc. | 07/30 | +25 % | 68 6/22 | Stage 2 | B 61 | 4 of 9 | 4.5 $ | Drug Manufacturers - Specialty & Generic | Neutral | — | Healthcare | 40.00 $ | +11.4 % | +14.1 % | +98.1 % | −1.9 % | +27.1 % | 90 | 83 | 3.6 % | 3.6 % | 1.15 | 20.8 | 13.0 | 3.5 | 140.7 | — | — | 14.3 | 46.1 % | 85.0 % | 19.5 % | 12.2 % | 22.7 % | -3.49 | -12.0 % | +4.3 % | — | 0.0 % | 0.0 % | 3.6 | 107.5 % | 11.3 % | 4.7 (7) | |
| LINC Lincoln Educational Services Corporation | 08/10 | +218 % | 99 10/16 | Stage 2 | B 69 | 6 of 9 | 1.3 $ | Education & Training Services | – | — | — | Consumer Defensive | 41.80 $ | +95.1 % | +99.0 % | +82.9 % | −8.4 % | +37.3 % | 90 | 88 | 4.8 % | 4.6 % | 0.79 | 59.1 | 52.9 | 2.4 | 6.7 | — | 3.53 | 27.4 | 4.5 % | 60.3 % | 4.1 % | 11.9 % | 4.4 % | 1.04 | 40.8 % | +17.8 % | — | 0.0 % | 0.0 % | 4.9 | 88.7 % | 11.2 % | 4.8 (5) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Zanger's real strategy (not the widely circulated 'Liquid High Beta' variant). He buys institutional market leaders: explosive earnings growth (≥ 50%), top relative strength, high-priced liquid stocks near their highs, market cap up to $10 billion — and only enters on a volume breakout (≥ 300% of average) out of a base. This screener delivers the leader watchlist; the breakout itself is discretionary.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 16 stocks pass this scanner's criteria (as of 3. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- Ben Bennett: Focus List
- Ben Bennett: Power Screen
- EPS & Revenue Power
- EPS Acceleration
- High Revenue Growth
- Jim Roppel: 20/20 Screen
- Joshua
- Martin Zweig: Growth with Reason
- Matt Caruso: Sales Leader
- Patrick Walker: 30% EPS Growth
- Patrick Walker: 40, 40 Screen
- Quality Growth
- Small Caps with Growth
- Ted Zhang: Super Stock Universe
- Thomas' Favorites
- Triple-Digit Revenue Growth
- William O'Neil (CAN SLIM)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.